Advanced search
Publication Cover
Platelets Volume 23, 2012 - Issue 2
Submit an article Journal homepage
197
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease

Mirjana MitrovicClinics of Hematology CCS, 2, Koste Todorovica, Beograd 11000, SerbiaCorrespondence[email protected]
,
Darko AnticClinics of Hematology CCS, 2, Koste Todorovica, Beograd 11000, Serbia
,
Ivo ElezovicClinics of Hematology CCS, 2, Koste Todorovica, Beograd 11000, Serbia;Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia
,
Dragana JanicFaculty of Medicine, University of Belgrade, Belgrade 11000, Serbia;Department of Hematology and Oncology, University of Children Hospital, Belgrade 11000, Serbia
,
Predrag MiljicClinics of Hematology CCS, 2, Koste Todorovica, Beograd 11000, Serbia;Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia
,
Zorica SumaracInstitute of Medical Biochemistry, CCS, Belgrade 11000, Serbia
,
Tanja NikolicInstitute of Radiology, CCS, Belgrade 11000, Serbia
&
Nada SuvajdzicClinics of Hematology CCS, 2, Koste Todorovica, Beograd 11000, Serbia;Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia
 show all
Pages 143-149 | Received 31 Oct 2010, Accepted 13 Jun 2011, Published online: 19 Jul 2011

References

  • Butler E, Grabowski G. Gaucher disease. The metabolic basis of inherited disease, CR Scriver, WS Sly, D Valle. McGraw-Hill Publishing Company, New York 1995; 2641–2670
  • Berrebi A, Malnick SD, Vorst EJ, Vorst EJ, Stein D. High incidence of factor XI deficiency in Gaucher's disease. Am J Hematol 1992; 40: 153–161
  • Humphries JE, Hess CE. Gaucher's disease and acquired coagulopathy. Am J Hematol 1994; 45: 347–348
  • Billett HH, Rizvi S, Sawitski A. Coagulation abnormalities in patients with Gaucher's disease: Effect of therapy. Am J Hematol 1996; 51: 234–236
  • Hollak CEM, Levi M, Berneds F, Aerts JM, van Oers MH. Coagulation abnormalities in type 1 Gaucher disease are due low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol 1997; 96: 470–476
  • Aerets JMFG, Hollak C. Plasma and metabolic abnormalities in Gaucher disease. Balliere's Clinical Hematology 1997; 10: 691–707
  • Gillis S, Hyam E, Abrahamov A, Elstein D, Zimran A. Platelet function abnormalities in Gaucher disease patients. Am J Hematol 1999; 61: 103–106
  • Barone R, Giuffrida G, Musso R, Carpinteri G, Fiumara A. Haemostatic abnormalities and lupus anticoagulant activity in patients with Gaucher disease type I. J Inherit Metab Dis 2000; 23: 387–390
  • Zimran A, Altarescu G, Rundensky B. Survey of hematological aspects of Gaucher disease. Hematology 2005; 10: 151–156
  • Giona F, Palumbo G, Amendola A, Santoro C, Mazzuconi MG. Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: Effects of enzyme replacement therapy (ERT). J Thromb Haemost 2006; 4: 1831–1833
  • Lešić A, Suvajdžić N, Elezović I, Bumbasirevic M, Hadas-Halpern I, Elstein D, Zimran A. Ileopsoas hematoma in Gaucher disease. J Inherit Metab Dis 2006; 29(4): 593
  • Deghady A, Marzouk I, El- Shayeb A, Wali Y. Coagulation abnormalities in type 1 Gaucher disease in children. Ped Hem and Onc 2006; 23: 411–417
  • Simchen MJ, Oz R, Shenkman B, Zimran A, Elstein D, Kenet G. Impaired platelet function and peripartum bleeding in women with Gaucher disease. Thromb Haemost 2011; 105: 509–514
  • Spectre G, Roth B, Ronen G, Rosengarten D, Elstein D, Zimran A, Varon D, Revel-Vilk S. Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding. Br J Haematol 2011; Mar 9. doi: 10.1111/j.1365-2141.2011.08613
  • Kelsey H, Cristopopulos C, Gray AA. Acquired pseudo-pseudo Bernard–Soulier syndrome complicating Gaucher disease. J Clin Pathol 1994; 47: 162–165
  • Hoffman R. Molecular basis of platelet aggregation. Haematology: Basic pronciples and pratice, R Hoffman. Churchill Livingstone an imprint of Elsevier Inc, Philadelphia 2008; 1320–1437
  • The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force. Guidelines on platelet function testing. J Clin Pathol 1988;41:1322–1330
  • Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: Increased release of interleukin-6 and interleukin-10. Quart J Med 1997; 90: 19–25
  • Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S. Cytokines in Gaucher's disease. Eur Cytokine Netw 1999; 10: 205–210
  • Hollak CE, Evers L, Aerts JM, van Oers MH. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells, Molecules and Diseases 1997; 23: 201–212
  • Jmoudiak M, Futerman AH. Gaucher disease: Pathological mechanisms and modern management. Br J Haematol 2005; 129: 178–188

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.